(a) CKD patients
Before paricalcitol | After paricalcitol | |||
---|---|---|---|---|
PBMC + PHA | PBMC | PBMC + PHA | PBMC | |
(10 μg/mL) | (10 μg/mL) | |||
IL-17 (pg/mL) | 39 ± 6.2 | <15 | 19 ± 3.8 | <15 |
IL-6 (pg/mL) | 66 ± 9.8 | <1.4 | 31 ± 5.9 | <1.4 |
IFN-γ (pg/mL) | 174 ± 32.9 | <1.5 | 78 ± 11.7 | <1.5 |
IL-1β (pg/mL) | 97 ± 13.3 | <1 | 42 ± 4.3 | <1 |
TNF-α (pg/mL) | 202 ± 31.4 | <1.6 | 104 ± 15.8 | <1.6 |
NGAL (ng/mL) | 78 ± 9.2 | <0.1 | 21 ± 4.1 | <0.1 |